Advanced therapies
Imperial to be part of new London Advanced Therapies Treatment Centre
Imperial to join ATTC Network
Imperial to be part of new London Advanced Therapies Treatment Centre
Imperial to join ATTC Network
Ultrafast probing and AI-enabled drug discovery: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Dizziness in older adults linked to higher risk of future falls
The first meta-analysis of its kind has shown that older adults experiencing dizziness are significantly more likely to fall in future.
Imperial joins inaugural Royal Society fellowship for Black-heritage researchers
The Royal Society Career Development Fellowship is a new initiative designed to support early career researchers from Black-heritage backgrounds.
Developing a new test to improve sepsis outcomes
In advance of World Sepsis Day, Imperial and MicrosensDx announce a collaboration to develop a more effective test for the devastating disease.
NHS using Imperial spinout’s advanced prescription software to improve safety
Imperial spinout Dosium is working with the NHS to roll out a clinical decision support tool that provides dosage guidance to increase patient safety.
Sex hormones modulate the immune system to influence disease risk differently
Researchers have uncovered how hormones profoundly affect our immune systems, explaining why men and women are affected by diseases differently.
Brain fluid surgery to a world-first lunar-Earth flyby: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Feature
Professor Jonathan Weber reflects on his time as AHSC Director
Leading HIV expert Professor Jonathan Weber has stepped down as Imperial College Academic Health Science Centre (AHSC) Director.
Food allergy doubles in the UK over last decade but many still without treatment
The number of people with food allergy in the UK has more than doubled since 2008, with the largest increase seen in young children.